cytena GmbH has developed a device called cy-Clone to separate single cells. Single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research. The cy-Clone is supported by an automated imaging process to encapsulate cells indroplets, which are delivered to any type of substrate. Thanks to this particularly gentle delivery method, the cells are able to survive post printing and can either be analyzed thereafter or grown into clonal colonies. To determine clonality, multiple images are recorded during the process. Cross-contamination is avoided by the use of disposable parts.

Biotechnology

Health Care

CYTENA

Julian Riba

Jochen Huck

Elio Macias Ramírez

Dominic Olavarría-Peters

Edmund Yap

Yafees Sarwar

Andreas H.

Lena Lautscham

John Carroll

Fernando Aprile García

Dominik Bernhardt

The Sales and Marketing team at CYTENA focuses on promoting and selling the cy-Clone device, which is pivotal for single-cell analysis in drug development and cancer research. This team engages with clients across various regions, including North America and Europe, to demonstrate the device's innovative technology and its applications in biotechnology. They drive revenue growth through strategic marketing initiatives and sales efforts, ensuring effective communication of the product's benefits to target markets while fostering strong customer relationships.

Sales and Marketing

Operations and Project Management

Leadership Team

Sales and Marketing

About

Team members

Other teams at CYTENA

Operations and Project Management

Leadership Team